Discover the detailed record of transactions filed by Kimball Aaron, Officier. Officer active across 1 companies, notably Zymergen Inc.. Aggregated, 12 disclosures have been published. Total volume traded: €829k. The latest transaction was filed on 1 April 2022 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Aaron Kimball is the Chief Technology Officer of Zymergen Inc. In this role, he oversees the company's technology operations. Zymergen is a biotechnology company specializing in innovation. Aaron plays a key role in developing new technologies and innovation.